相关实验视频
Updated: Jun 29, 2025

08:35
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
10.2K
在不同心力衰竭表型中绘制免疫蛋白酶和自的相互作用
1German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Molecular Toxicology, Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
Free radical biology & medicine
|April 3, 2024
概括
免疫蛋白酶体 (i20S) 在心力衰竭中起着双重作用,在某些疾病中水平上升,在其他疾病中降低. 了解它与自的相互作用可能会揭示新的心力衰竭治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 心血管研究的心血管研究.
- 生物化学 生物化学
背景情况:
- 蛋白质稳态对于器官功能至关重要,特别是在心肌细胞中.
- 由炎症和氧化应激驱动的功能失调的蛋白质降解,有助于心脏病.
- 无素-蛋白酶体系统和自-溶酶体通路是细胞降解的关键系统.
研究的目的:
- 审查免疫蛋白酶体 (i20S) 在各种心力衰竭表型中的双重作用.
- 探索心脏功能障碍中的i20S和自之间的关系.
- 为了确定心力衰竭治疗的潜在治疗点.
主要方法:
- 关于i20S在心力衰竭中的研究的文献综述.
- 在不同心力衰竭模型中分析i20S表达.
- 检查连接i20S和自的信号通路.
主要成果:
- 在心脏缩,心房动和心肌炎中,i20S子单位升高.
- 在糖尿病心肌病和缺血/再输液损伤时,i20S水平下降.
- 根据心力衰竭的类型,i20S会对自产生不同的影响.
结论:
- 免疫蛋白酶体在心脏损伤中表现出上下文依赖的作用.
- 准i20S-自轴为心力衰竭提供了一个有希望的治疗途径.
- 对i20S调制的进一步研究可能会导致新的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome
6.5K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
The Proteasome
832
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
832

